BioNexus Gene Lab Corp (BGLC): Revenue
$7.42M
Year ended 2025-12-31
$3.13M
Trailing 12 months to 2026-06-30
-12.1%
3-year compound annual growth
-8.2%
5-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $7.42M | -21.9% | 2026-04-14, From 2025-01-01 |
| 2024-12-31 | $9.51M | -2.7% | 2026-04-14, From 2024-01-01 |
| 2023-12-31 | $9.77M | -10.6% | 2025-04-15, From 2023-01-01 |
| 2022-12-31 | $10.93M | -18.2% | 2024-04-16, From 2022-01-01 |
| 2021-12-31 | $13.36M | +17.3% | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | $11.39M | n/m | 2022-04-06, From 2020-01-01 |
| 2019-12-31 | $127.0K | -40.2% | 2021-03-30, From 2019-01-01 |
| 2018-12-31 | $212.3K | n/a | 2020-03-31, From 2018-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| BioNexus Gene Lab Corp (BGLC) | 2025-12-31 | $7.42M | -21.9% |
| American Shared Hospital Services (AMS) | 2025-12-31 | $28.08M | -0.9% |
| Exagen Inc. (XGN) | 2025-12-31 | $66.58M | +19.7% |
| Personalis, Inc. (PSNL) | 2025-12-31 | $69.65M | -17.7% |
| Biodesix Inc (BDSX) | 2025-12-31 | $88.50M | +24.1% |
| YD Bio Ltd (YDES) | 2025-12-31 | $596.8K | +16.9% |
| GRAIL, Inc. (GRAL) | 2025-12-31 | $147.17M | +17.2% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $305.11M | +100.0% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $322.67M | +13.8% |
Compare BGLC, AMS, XGN, PSNL side by side · Screen every company in Services-Medical Laboratories ↗